Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection.

AIMS The early diagnosis of acute aortic dissection (AD) remains challenging. We sought to determine the utility of the troponin-like protein of smooth muscle, calponin, as a diagnostic biomarker of acute AD. METHODS AND RESULTS Immunoassays against calponin (acidic, basic, and neutral isoforms) were developed and the levels were compared in a convenience sample of 59 patients with radiographically proven AD [34 males, age 59 +/- 15 (SD) years] vs. 158 patients suspected of having AD at presentation (116 males, age 63 +/- 15 years) but whose final diagnosis was not AD. Basic calponin, which is the most specific and abundant in smooth muscle, and acidic calponin, respectively, showed greater than two-fold and three-fold elevations in patients with acute AD. Diagnostic performance as determined by receiver-operating characteristics curve analysis showed that both acidic and basic calponin have the potential to detect AD in the first 24 h [respective areas under the curve (AUCs) 0.63 and 0.58], with superior performance of basic calponin (when compared with acidic) in the initial 6 h (respective AUCs 0.63 and 0.67). CONCLUSION Circulating calponin levels were elevated in acute AD compared with controls. These biomarkers have the potential for use as an early diagnostic biomarker for acute AD.

[1]  H. Litt,et al.  Evaluation of the patient with acute chest pain. , 2010, Radiologic clinics of North America.

[2]  K. Eagle,et al.  Acute Aortic Syndromes , 2005, Circulation.

[3]  K. Eagle,et al.  Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. , 2003, Circulation.

[4]  E. Braunwald,et al.  Acute coronary syndrome without ST elevation: implementation of new guidelines , 2001, The Lancet.

[5]  M. Walsh.  Calponin — knocked out but not down! , 2000, The Journal of physiology.

[6]  M. Nobuyoshi,et al.  Diagnostic Implications of Elevated Levels of Smooth-Muscle Myosin Heavy-Chain Protein in Acute Aortic Dissection: The Smooth Muscle Myosin Heavy Chain Study , 2000, Annals of Internal Medicine.

[7]  E. Isselbacher,et al.  The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. , 2000, JAMA.

[8]  T. Suzuki,et al.  Biochemical diagnosis of aortic dissection: from bench to bedside. , 1999, Japanese heart journal.

[9]  Y. Yazaki,et al.  Biochemical diagnosis of aortic dissection by raised concentrations of creatine kinase BB-isozyme , 1997, The Lancet.

[10]  Y. Yazaki,et al.  Novel biochemical diagnostic method for aortic dissection. Results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. , 1996, Circulation.

[11]  Y. Yazaki,et al.  A novel immunoassay of smooth muscle myosin heavy chain in serum. , 1995, Journal of immunological methods.

[12]  Katsuhito Takahashi.  Vascular Smooth Muscle Calponin , 1995 .

[13]  Y. Hiroi,et al.  Diagnosis of aortic dissection by immunoassay for circulating smooth muscle myosin , 1995, The Lancet.

[14]  A. Tajik,et al.  Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). , 1993, Mayo Clinic proceedings.

[15]  R. C. Seelman,et al.  TREATMENT OF DISSECTING ANEURYSMS OF THE AORTA WITHOUT SURGERY. , 1965, The Journal of thoracic and cardiovascular surgery.

[16]  D. Cooley,et al.  Surgical Considerations of Dissecting Aneurysm of the Aorta , 1955, Annals of surgery.

[17]  高橋 克仁.  Vascular smooth muscle calponin : a novel troponin T-like protein , 1988 .